Compositions for preventing and treating infection
Compositions for preventing and treating infection
Composition including an artificial sweetener (e.g. ace-K, saccharin, sucralose, cyclamate, sugar alcohol (e.g. xylitol, mannitol, sorbitol, erythritol, maltitol, lactitol)) or a derivative thereof in an amount sufficient to inhibit bacterial growth and/or virulence for use in a method of treating and/or preventing infection (e.g. infection caused by Pseudomonas aeruginosa, Acinetobacter baumannii, Enterococcus faecalis, Klebsiella pneumoniae, Stenotrophomonas maltophilia or an Enterobacter species. Such compositions may inhibit biofilm formation and/or bacterial motility. Further claimed is a composition including acesulfame potassium, cyclamate, saccharin or a derivative thereof, for use in enhancing the activity of an antibiotic, preferably wherein the acesulfame-K, saccharin or cyclohexylsulfamate are present below a minimum inhibitory concentration, most preferably present at less than 1 % (w/v), such a composition may be co-administered with a beta-lactam, carbapenem, aminoglycoside, polymyxin. The compositions may be applied topically, orally, intravenously or via inhalation.
GB2617603
Intellectual Property Office
18 October 2023
Ronan, McCarthy
0b2cf2e0-b0ff-4c92-aa04-92d91182d1f2
Ronan, McCarthy
(Inventors)
(2023)
Compositions for preventing and treating infection.
GB2617603.
Abstract
Composition including an artificial sweetener (e.g. ace-K, saccharin, sucralose, cyclamate, sugar alcohol (e.g. xylitol, mannitol, sorbitol, erythritol, maltitol, lactitol)) or a derivative thereof in an amount sufficient to inhibit bacterial growth and/or virulence for use in a method of treating and/or preventing infection (e.g. infection caused by Pseudomonas aeruginosa, Acinetobacter baumannii, Enterococcus faecalis, Klebsiella pneumoniae, Stenotrophomonas maltophilia or an Enterobacter species. Such compositions may inhibit biofilm formation and/or bacterial motility. Further claimed is a composition including acesulfame potassium, cyclamate, saccharin or a derivative thereof, for use in enhancing the activity of an antibiotic, preferably wherein the acesulfame-K, saccharin or cyclohexylsulfamate are present below a minimum inhibitory concentration, most preferably present at less than 1 % (w/v), such a composition may be co-administered with a beta-lactam, carbapenem, aminoglycoside, polymyxin. The compositions may be applied topically, orally, intravenously or via inhalation.
This record has no associated files available for download.
More information
Published date: 18 October 2023
Identifiers
Local EPrints ID: 508331
URI: http://eprints.soton.ac.uk/id/eprint/508331
PURE UUID: 69bccbc5-d62e-499e-924c-d58050bd8a0f
Catalogue record
Date deposited: 19 Jan 2026 17:32
Last modified: 20 Jan 2026 03:14
Export record
Contributors
Inventor:
McCarthy Ronan
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics